Menu
中文Book a checkup
St. Martin De Porres Hospital · Chiayi · Regional hospital

Advanced Imaging B Checkup

US$810
NT$26,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call St. Martin De Porres Hospital on 05-2756000 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Coronary artery calcium score, Low-dose chest CT, Abdominal ultrasound, Thyroid ultrasound and Bone density (DXA) and a 63-test panel.

Fasting
8 hours before
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Thyroid ultrasound

Thyroid nodules.

Every test, in English

63 tests listed, 51 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count3
Liver Function10
Kidney & Electrolytes4
Lipids & Cardiometabolic4
Glucose2
Thyroid & Endocrine1
Tumor Markers3
Infection Serology3
Urine & Stool2
Cardiac3
X-ray1
Ultrasound2
CT Imaging2
Bone & Body Composition2
Eye3
ENT & Dental1
Show all 63 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Iron studiesIron deficiency or iron overload.
Rheumatoid factor (RF)A marker associated with rheumatoid arthritis.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
Lactate dehydrogenaseNon-specific tissue damage marker.
Total bilirubinJaundice, liver and bile problems.
Total proteinNutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
CA-125Ovarian cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Urine microalbumin / ACREarly kidney damage, especially in diabetes and hypertension.
Cardiac
Arterial stiffness (ABI / PWV)Peripheral artery disease and arterial stiffness.
Creatine kinaseMuscle and heart muscle damage.
Resting ECGHeart rhythm and signs of prior heart damage.
X-ray
Chest X-rayLung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Thyroid ultrasoundThyroid nodules.
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Muscle mass and strength (sarcopenia)Age-related muscle loss.
Eye
Color visionColor vision deficiency.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
ENT & Dental
Hearing testHearing loss.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Iron studies
Iron deficiency or iron overload.
Rheumatoid factor (RF)
A marker associated with rheumatoid arthritis.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Lactate dehydrogenase
Non-specific tissue damage marker.
Total bilirubin
Jaundice, liver and bile problems.
Total protein
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
CA-125
Ovarian cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
Infection Serology
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Urine microalbumin / ACR
Early kidney damage, especially in diabetes and hypertension.
Cardiac
Arterial stiffness (ABI / PWV)
Peripheral artery disease and arterial stiffness.
Creatine kinase
Muscle and heart muscle damage.
Resting ECG
Heart rhythm and signs of prior heart damage.
X-ray
Chest X-ray
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Coronary artery calcium score
Calcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CT
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Muscle mass and strength (sarcopenia)
Age-related muscle loss.
Eye
Color vision
Color vision deficiency.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
ENT & Dental
Hearing test
Hearing loss.
Also listed: AFP (alpha-fetoprotein), Body type assessment, Family medicine physician examination with one-on-one report review and health education, Fecal immunochemical test (FIT), H. pylori stool antigen test, Head and neck CT, with contrast, Hyperbaric oxygen session (40 minutes), MCH (mean corpuscular hemoglobin), PSA (prostate-specific antigen), male, Total body water, Urine sediment microscopy, Visceral fat index.

Before you book

Fasting8 hours before
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
St. Martin De Porres Hospital
Regional hospital
Chiayi · East

2.7 km from Chiayi station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

13 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

  • The 7th-floor health management center is open Monday to Saturday, 08:00 to 11:30.

    Source ↗ · checked 2026-09-20

  • The 6th-floor health management center is open Monday to Friday, 13:00 to 16:30.

    Source ↗ · checked 2026-09-20

Results

  • The health checkup report is expected to be sent out within 14 days of the checkup date.

    Source ↗ · checked 2026-09-20

  • Patients can choose to have their health checkup report sent by mail.

    Source ↗ · checked 2026-09-20

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
CA 15-3as listed: Breast cancer marker (CA-153)
US$16
NT$500
For women
Exercise stress ECGas listed: Treadmill EKG (exercise stress ECG)
US$42
NT$1,350
Echocardiogramas listed: Heart echo (echocardiogram)
US$93
NT$3,000
Carotid ultrasound
US$53
NT$1,700
Cervical spine MRIas listed: Cervical spine MRI (2 sequences)
US$93
NT$3,000
22 sequences
Lumbar spine MRIas listed: Lumbar spine MRI (2 sequences)
US$93
NT$3,000
22 sequences
Brain MRI
US$249
NT$8,000
Brain MRIas listed: Brain MRI with contrast
US$405
NT$13,000
Breast MRIas listed: Breast MRI with contrast
US$405
NT$13,000
For women
Mammographyas listed: 3D mammography
US$100
NT$3,200
For women
APOE genotypeas listed: Alzheimer's risk assessment (APOE genotype)
US$62
NT$2,000

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$2,473–3,590 for a woman (51 of 51 tests) and US$2,439–3,556 for a man (50 of 50 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 3.3 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.1 years of natural background radiation (about 3 mSv a year, US average).

Not counted: Head and neck CT, with contrast. If it is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Low-dose chest CT · about 1.5 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 21 of these tests
Arterial stiffness (ABI / PWV)
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding the ankle-brachial index to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement that is limited to coronary artery calcium scoring; its September 2024 research plan excludes the ABI, which it says will be evaluated as a screening test in a separate future topic on peripheral artery disease.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ankle-brachial index in asymptomatic adults. (2018) · USPSTF ↗ Note: A separate statement from the nontraditional-risk-factor one; see the other abi_pwv row. Neither USPSTF statement mapped here addresses pulse wave velocity (arterial stiffness).
Hepatitis C antibody
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Hearing test
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Blood pressure
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Bone density (DXA)
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
CA 19-9
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Coronary artery calcium score
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hepatitis B surface antigen
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
HDL cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Height, weight and BMI
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Intraocular pressure
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Low-dose chest CT
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Resting ECG
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Thyroid ultrasound
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Urinalysis
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Visual acuity
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 11 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Advanced Imaging B Checkup
US$810
Book this checkup

If this isn't quite right

Same hospital, cheaper
Advanced Imaging A Checkup
St. Martin De Porres Hospital
US$498
Same hospital, adds Abdomen and pelvis CT
Distinguished Men Checkup
St. Martin De Porres Hospital
US$1,090
Same focus, Taipei
Standard Elite Package
Chang Gung Memorial Hospital Taipei Health Examination Center
US$794

Other packages at St. Martin De Porres Hospital

PackageTestsPrice
Brunch Vitality Checkup - Plan A23
US$78
NT$2,500
Civil Servant Checkup Plan A (Guardian Health Plan)Civil-servant36
US$140
NT$4,500
Civil Servant Checkup - Cardiovascular PlanCivil-servant40
US$249
NT$8,000
Advanced Imaging A Checkup62
US$498
NT$16,000
Civil Servant Checkup - Endoscopy PlanCivil-servant41
US$498
NT$16,000
Painless Sedation Health Checkup A66
US$810
NT$26,000
Distinguished Men Checkup55
US$1,090
NT$35,000
Painless Sedation Health Checkup B72
US$1,121
NT$36,000
Radiant Goddess Checkup54
US$1,184
NT$38,000
Advanced Imaging C Checkup68
US$1,308
NT$42,000

All packages at St. Martin De Porres Hospital →

Similar packages in Chiayi

Same tier, other hospitals in Chiayi, closest in price first.
PackageHospitalTestsPrice
Refined Health CheckupDalin Tzu Chi Hospital Health Examination Center46
US$768
NT$24,660
Women US$778
Advanced Weekend 2-Day Health CheckupDalin Tzu Chi Hospital Health Examination Center54
US$864
NT$27,720
Women US$936
Advanced Health CheckupDalin Tzu Chi Hospital Health Examination Center58
US$910
NT$29,210
Women US$983

All checkups in Chiayi →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Heart and blood vessels · Lung · All checkups in Chiayi · What a checkup costs in Taiwan